Development of PTH Eluting Microspheres for the Treatment of Hypoparathyroidism

Journal of Surgical Research

Volumn 143, Issue 2, 2007, Pages 195-199

  Fong, Peter ^a   Goyal, Amit ^a   Brennan, Matthew ^a   Park, Jason ^a   Moss, Lawrence ^a   Saltzman, W Mark ^a   Breuer, Christopher K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

drug delivery; microspheres; negative feedback; parathyroid hormone (PTH)

Indexed keywords

CALCIUM; CALMODULIN; MICROSPHERE; PARATHYROID HORMONE[1-34]; POLYGLYCOLIC ACID; POLYLACTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; DRUG RELEASE; ELECTRON MICROSCOPY; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HORMONE ACTION; HYPOPARATHYROIDISM; IN VITRO STUDY; IN VIVO STUDY; MALE; NEGATIVE FEEDBACK; NONHUMAN; PARATHYROID HORMONE RELEASE; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; CALCIUM; CALMODULIN; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; FEEDBACK, BIOCHEMICAL; HORMONE REPLACEMENT THERAPY; HYPOPARATHYROIDISM; INJECTIONS, SUBCUTANEOUS; LACTIC ACID; MALE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARATHYROID HORMONE; POLYGLYCOLIC ACID; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 36048988750     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.04.009     Document Type: Article

References (14)

1. Thomusch O., Machens A., Sekulla C., Ukkat J., Brauckhoff M., and Dralle H. The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: A multivariate analysis of 5846 consecutive patients. Surgery 133 (2003) 180
2. Falk S.A., Birken E.A., and Baran D.T. Temporary postthyroidectomy hypocalcemia. Arch Otolaryngol Head Neck Surg 114 (1998) 168
3. Percival R.C., Hargreaves A.W., and Kanis J.A. The mechanism of hypocalcemia following thyroidectomy. Acta Endocrinol 109 (1985) 220
4. See A.C.H., and Soo K.C. Hypocalcemia following thyroidectomy for thyrotoxicosis. Br J Surg 84 (1997) 95
5. Burney R.E., Jones K.R., Coon J.W., et al. Assessment of patient outcomes after operation for primary hyperparathyroidism. Surgery 120 (1996) 1013
6. Strogmann W., Bohrn E., and Woloszczuk W. First experiences in the substitution treatment of hypoparathyroidism with synthetic human parathyroid hormone. Monatsschr Kinderheilkd 138 (1990) 141
7. Winer K.K., Yanovski J.A., and Cutler G.B. Synthetic human parathyroid hormone 1-34 vs calcitrol and calcium in the treatment of hypoparathyroidism: Results of a short-term randomized crossover trial. JAMA 276 (1996) 631
8. Winer K.K., Yanovski J.A., Sarani B., and Cutler G.B. A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism. J Clin Endocrinol Metab 83 (1998) 3480
9. Leone-Bay A., Sato M., Paton D., et al. Oral delivery of biologically active parathyroid hormone. Pharm Res 18 (2001) 961
10. Patton J.S., Trinchero P., and Platz R.M. Bioavailability of pulmonary delivered peptides and proteins: A-interferon, calcitonins, and parathyroid hormones. J Control Rel 28 (1994) 79
11. Condrons B., Vanderbist F., Ucakar B., Preat V., and Vanbever R. Impact of formulation and methods of pulmonary delivery on absorption of parathyroid hormone (1-34) from rat lungs. J Pharm Sci 93 (2004) 1241
12. Perets A., Baruch Y., Weisbuch F., Shoshany G., Neufeld G., and Cohen S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res 65A (2003) 489
13. Eiselt P., Kim B.S., Chacko B., et al. Development of technologies aiding large-tissue engineering. Biotechnol Prog 14 (1998) 134
14. Saltzman W.M., Mak M., Mahoney M.H., Duenas E.T., and Cleland J.L. Intracranial delivery of recombinant nerve growth factor: Release kinetics and protein distribution for three delivery systems. Pharm Res 16 (1999) 232